Please use this identifier to cite or link to this item:
|Title:||Biomedical applications of human cathelicidin|
|Author(s):||Gama, F. M.|
Silva, João P.
|Citation:||Gama, F. M.; Silva, João P.; Martins-Green, Manuela; Castro, Gil; Pedrosa, Jorge; Appelberg, Rui, Biomedical applications of human cathelicidin. MicroBiotec'15 - Congress of Microbiology and Biotechnology 2015. Évora, Portugal, Dec 10-12, 63-63, 2015.|
|Abstract(s):||[Excerpt] Antimicrobial peptides (AMPs) are good candidates to treat burn wounds, a major cause of morbidity, impaired life quality and resources consumption in developed countries. Tuberculosis (TB), a disease caused by the human pathogen Mycobacterium tuberculosis, represents the second world’s deadliest infectious disease, affecting around 9 million people worldwide in 2013. Of those, about 1.1 million died from the disease. The potential of cathelicin, a human AMP, in the treatment of mycobacteriosis and wound regeneration was assessed in pre-clinical trials. (...)|
|Appears in Collections:|